FDA – Public meeting on Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products (Catapult’s regulatory round-up May)
The FDA held a public meeting on the “Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products” on the 26th of May 2023.
Published on the 2nd of June 2023. Read the entire regulatory round-up for the month of May published and curated by Catapult here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (21 février 2024). FDA – Public meeting on Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products (Catapult’s regulatory round-up May). ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/vvhy





